PI3K/mTOR-IN-17
PI3K/mTOR-IN-17 is a dual PI3K and mTOR inhibitor with IC50 values of 1.21 μM (PI3K), and 0.21 μM (mTOR). PI3K/mTOR-IN-17 induces cells caspase-mediated apoptosis by arresting their growth in the G1-phase. PI3K/mTOR-IN-17 upregulates the levels of caspases-3, 7, 8, and 9, p53 expression and Bax/Bcl-2 ratio. PI3K/mTOR-IN-17 suppresses the PI3K/mTOR signaling pathway. PI3K/mTOR-IN-17 can be used for research of cancer, such as non-small cell lung cancer (NSCLC).
For research use only. We do not sell to patients.
- Formula: C36H34N4O6
- Molecular Weight:618.68
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
PI3K 1.21 μM (IC50) |
mTOR 0.21 μM (IC50) |
Caspase 3 |
Caspase-7 |
Caspase-8 |
Caspase-9 |
Bax |
Bcl-2 |
In Vitro
PI3K/mTOR-IN-17 (Compound 8) shows superior cytotoxicity with IC50 values of 21.13 μM (lung fibroblasts WI-38) and 1.39 μM (A549 cells), and selectivity index of 15.32[1].
PI3K/mTOR-IN-17 (1.39 μM, 48 h) upregulates the leves of p53 and Bax, and downregulates the leves of Bcl-2, EGFR, PI3K and mTOR in A549 cells[1].
PI3K/mTOR-IN-17 (1.39 μM, 48 h) upregulates the initiator caspase-8 and 9 levels and the executioner caspases-3 and 7 levels in A549 cells[1].
PI3K/mTOR-IN-17 (1.39 μM, 48 h) induces significantly apoptosis by arresting their growth in the G1-phase in A549 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A549 lung cancer cells
-
Concentration:1.39 μM
-
Incubation Time:48 h
-
Result:Significantly increased the expression of p53 by 8.38 folds Bax by 9.88 fold and downregulated the leves of Bcl-2 by 0.45 fold.
Suppressed gene expression of EGFR by 0.42 fold, PI3K by 0.45 fold, and mTOR by 0.58 fold.
-
Cell Line:A549 lung cancer cells
-
Concentration:1.39 μM
-
Incubation Time:48 h
-
Result:Significantly increased the overall death rate by 21 fold.
Total apoptosis reached 25.03% (19.38% late apoptosis, 5.65% early apoptosis) compared to 1.19% in the untreated control group.
Markedly increased the cell population in the G1-phase to 80.2% compared to 57.3% in the control, and reduced the proportions of cells in the S and G2/M phases.
-
Cell Line:A549 lung cancer cells
-
Concentration:1.39 μM
-
Incubation Time:48 h
-
Result:Upregulated the initiator caspase-8 and 9 levels by almost 2.2 and 1.03 fold and the executioner caspases-3 and 7 by 1.73 and 1.34 fold.
Chemical Information
-
Molecular Weight 618.68
-
Formula C36H34N4O6
-
SMILES
O=C(N1C2=CC=C(NC(C(C3=CC=CC=C3)N(C4=CC=C(C)C=C4)C(CNC(OC(C)(C)C)=O)=O)=O)C=C2)C5=CC=CC=C5C1=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)